FDA says it plans the imminent release of a white paper outlining a new national medical device post-market surveillance strategy in the lead up to a public meeting on the topic Sept. 10. The agency will hold a series of meetings Sept. 10-13. The purpose of the Sept. 10 meeting, in Greenbelt, Md., is to seek feedback on the nascent post-market strategy.
On Sept. 11, FDA will hold its annual meeting for its public-private Medical Device Epidemiology Network (MDEpiNet) in Silver Spring,...